Drug Facts and Comparisons 2005.
59th ed. Facts & Companions; 2004.
Lexi-Comp. Alendronate. EBSCO Health Library, Lexi-PALS website. Available at: http://www.ebscohost.com/healthLibrary/. Updated March 9, 2010. Accessed October 25, 2010.
Lexi-Comp. Pamidronate. EBSCO Health Library, Lexi-PALS website. Available at: http://www.ebscohost.com/healthLibrary/. Updated March 9, 2010. Accessed October 25, 2010.
Lexi-Comp.
Raloxifene. EBSCO Health Library, Lexi-PALS website. Available at:
http://www.ebscohost.com/healthLibrary/. Updated March 9, 2010. Accessed June 18, 2010.
Osteoporosis. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed/what.php. Updated September 2008. Accessed September 23, 2008.
National Institutes of Health, Osteoporosis, and Related Bone Diseases Resource Center. National Institute of Arthritis and Musculoskeletal and Skin Diseases website. Available at:
http://www.niams.nih.gov/bone/.
National Osteoporosis Foundation
website. Available at:
http://www.nof.org/.
7/28/06 DynaMed's Systematic Literature Surveillance
http://www.epnet.com/dynamed/what.php: Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med.
2006;355(2):190-192.
6/4/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed/what.php: FDA approves new injectable osteoporosis treatment for postmenopausal women. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm214150.htm. Published June 1, 2010. Accessed June 4, 2010.
10/25/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed/what.php: US Food and Drug Administration. Possible increased risk of thigh bone fracture with bisphosphonates. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm. Published October 13, 2010. Accessed October 25, 2010.
3/11/2013 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed/what.php: Reid IR, Black DM, Eastell R, et al. Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. J Clin Endocrinol Metab. 2013 Feb;98(2):557-63.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.